Skip to main content
. 2016 Apr 21;18(7):982–990. doi: 10.1093/neuonc/now050

Table 1.

Clinical characteristics of the 3 molecular subtypes of adult medulloblastoma

Characteristic SHH (n = 124) WNT (n = 20) Group 4 (n = 57) P (χ2)
No. of Patients (%) No. of Patients (%) No. of Patients (%)
Sex
 Male 88 (70.97) 7 (35.00) 38 (66.67) .007
 Female 36 (29.03) 13 (65.00) 19 (33.33)
Tumor location
 Midline 55 (44.35) 14 (70.00) 43 (75.44) 1.9–e4
 Hemisphere 69 (55.65) 6 (30.00) 14 (24.56)
Tumor size
 ≤4 cm 59 (47.58) 13 (65.00) 29 (50.88) .349
 >4 cm 65 (52.42) 7 (35.00) 28 (49.12)
V4 floor involvement
 Yes 53 (42.74) 9 (45.00) 40 (70.18) .002
 No 71 (57.26) 11 (55.00) 17 (29.82)
Metastasis classification
 M0 104 (83.87) 18 (90.00) 44 (77.19) .282
 M+ 20 (16.13) 2 (10.00) 13 (22.81)
Surgical resection
 GTR 77 (62.10) 11 (55.00) 26 (45.61) .114
 STR 47 (37.90) 9 (45.00) 31 (54.39)
Histology
 CMB 58 (46.77) 19 (95.00) 37 (64.91) 1.5–e6
 DNMB 43 (34.68) 1 (5.00) 3 (5.26)
 LC/A MB 23 (18.55) 0 (0) 17 (29.83)
Risk
 Average 70 (56.45) 17 (85.00) 26 (45.61) .020
 High 54 (43.55) 3 (15.00) 31 (54.39)

Abbreviations: GTR, gross total resection; STR, subtotal resection; V4, fourth ventricle.